Cameroon’s Pharmaceutical Imports Reached CFA166.6bn in 2023

• 𝘽𝙚𝙩𝙬𝙚𝙚𝙣 2010 𝙖𝙣𝙙 2023, 𝘾𝙖𝙢𝙚𝙧𝙤𝙤𝙣’𝙨 𝙨𝙥𝙚𝙣𝙙𝙞𝙣𝙜 𝙤𝙣 𝙥𝙝𝙖𝙧𝙢𝙖𝙘𝙚𝙪𝙩𝙞𝙘𝙖𝙡 𝙞𝙢𝙥𝙤𝙧𝙩𝙨 𝙧𝙤𝙨𝙚 𝙨𝙝𝙖𝙧𝙥𝙡𝙮, 𝙛𝙧𝙤𝙢 𝘾𝙁𝘼69.5 𝙗𝙞𝙡𝙡𝙞𝙤𝙣 𝙩𝙤 𝘾𝙁𝘼166.6 𝙗𝙞𝙡𝙡𝙞𝙤𝙣, 𝙖𝙘𝙘𝙤𝙧𝙙𝙞𝙣𝙜 𝙩𝙤 𝙖 𝙧𝙚𝙥𝙤𝙧𝙩 𝙗𝙮 𝙩𝙝𝙚 𝘾𝙤𝙢𝙥𝙚𝙩𝙞𝙩𝙞𝙫𝙚𝙣𝙚𝙨𝙨 𝘾𝙤𝙢𝙢𝙞𝙩𝙩𝙚𝙚, 𝙖 𝙨𝙥𝙚𝙘𝙞𝙖𝙡𝙞𝙯𝙚𝙙 𝙪𝙣𝙞𝙩 𝙤𝙛 𝙩𝙝𝙚 𝙈𝙞𝙣𝙞𝙨𝙩𝙧𝙮 𝙤𝙛 𝙀𝙘𝙤𝙣𝙤𝙢𝙮. 𝙏𝙝𝙞𝙨 𝙧𝙚𝙥𝙧𝙚𝙨𝙚𝙣𝙩𝙨 𝙖 139.7% 𝙞𝙣𝙘𝙧𝙚𝙖𝙨𝙚, 𝙝𝙞𝙜𝙝𝙡𝙞𝙜𝙝𝙩𝙞𝙣𝙜 𝙩𝙝𝙚 𝙘𝙤𝙪𝙣𝙩𝙧𝙮’𝙨 𝙝𝙚𝙖𝙫𝙮 𝙧𝙚𝙡𝙞𝙖𝙣𝙘𝙚 𝙤𝙣 𝙛𝙤𝙧𝙚𝙞𝙜𝙣 𝙥𝙝𝙖𝙧𝙢𝙖𝙘𝙚𝙪𝙩𝙞𝙘𝙖𝙡 𝙥𝙧𝙤𝙙𝙪𝙘𝙩𝙨.

𝑻𝒉𝒆 𝒓𝒆𝒑𝒐𝒓𝒕 𝒅𝒊𝒅 𝒏𝒐𝒕 𝒔𝒑𝒆𝒄𝒊𝒇𝒚 𝒕𝒉𝒆 𝒒𝒖𝒂𝒏𝒕𝒊𝒕𝒊𝒆𝒔 𝒊𝒎𝒑𝒐𝒓𝒕𝒆𝒅 𝒐𝒓 𝒕𝒉𝒆 𝒄𝒐𝒖𝒏𝒕𝒓𝒊𝒆𝒔 𝒐𝒇 𝒐𝒓𝒊𝒈𝒊𝒏 𝒅𝒖𝒓𝒊𝒏𝒈 𝒕𝒉𝒊𝒔 𝒑𝒆𝒓𝒊𝒐𝒅. 𝑯𝒐𝒘𝒆𝒗𝒆𝒓, 𝒅𝒂𝒕𝒂 𝒇𝒓𝒐𝒎 𝑪𝒂𝒎𝒆𝒓𝒐𝒐𝒏’𝒔 𝑵𝒂𝒕𝒊𝒐𝒏𝒂𝒍 𝑰𝒏𝒔𝒕𝒊𝒕𝒖𝒕𝒆 𝒐𝒇 𝑺𝒕𝒂𝒕𝒊𝒔𝒕𝒊𝒄𝒔 (𝑰𝑵𝑺) 𝒔𝒉𝒐𝒘𝒔 𝒕𝒉𝒂𝒕 𝒊𝒏 2023, 𝑪𝒂𝒎𝒆𝒓𝒐𝒐𝒏 𝒊𝒎𝒑𝒐𝒓𝒕𝒆𝒅 4.2 𝒕𝒐𝒏𝒔 𝒐𝒇 𝒎𝒆𝒅𝒊𝒄𝒊𝒏𝒆𝒔 (𝒊𝒏𝒄𝒍𝒖𝒅𝒊𝒏𝒈 𝒗𝒆𝒕𝒆𝒓𝒊𝒏𝒂𝒓𝒚 𝒅𝒓𝒖𝒈𝒔) 𝒇𝒓𝒐𝒎 𝒕𝒉𝒆 𝑬𝒖𝒓𝒐𝒑𝒆𝒂𝒏 𝑼𝒏𝒊𝒐𝒏, 𝒘𝒐𝒓𝒕𝒉 𝑪𝑭𝑨62.9 𝒃𝒊𝒍𝒍𝒊𝒐𝒏. 𝑭𝒓𝒂𝒏𝒄𝒆 𝒘𝒂𝒔 𝒕𝒉𝒆 𝒍𝒆𝒂𝒅𝒊𝒏𝒈 𝒔𝒖𝒑𝒑𝒍𝒊𝒆𝒓 𝒘𝒊𝒕𝒉𝒊𝒏 𝒕𝒉𝒆 𝑬𝑼, 𝒆𝒙𝒑𝒐𝒓𝒕𝒊𝒏𝒈 2.017 𝒕𝒐𝒏𝒔 𝒐𝒇 𝒎𝒆𝒅𝒊𝒄𝒊𝒏𝒆𝒔 𝒗𝒂𝒍𝒖𝒆𝒅 𝒂𝒕 𝑪𝑭𝑨28.5 𝒃𝒊𝒍𝒍𝒊𝒐𝒏.

𝑰𝒏𝒅𝒊𝒂 𝒘𝒂𝒔 𝒂𝒍𝒔𝒐 𝒂 𝒎𝒂𝒋𝒐𝒓 𝒔𝒖𝒑𝒑𝒍𝒊𝒆𝒓 𝒊𝒏 2023. 𝑰𝑵𝑺 𝒅𝒂𝒕𝒂 𝒊𝒏𝒅𝒊𝒄𝒂𝒕𝒆𝒔 𝒕𝒉𝒂𝒕 𝒑𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝒊𝒎𝒑𝒐𝒓𝒕𝒔 𝒇𝒓𝒐𝒎 𝑰𝒏𝒅𝒊𝒂 𝒂𝒄𝒄𝒐𝒖𝒏𝒕𝒆𝒅 𝒇𝒐𝒓 7% 𝒐𝒇 𝒕𝒉𝒆 𝒕𝒓𝒂𝒅𝒆 𝒗𝒐𝒍𝒖𝒎𝒆, 𝒘𝒊𝒕𝒉 𝒂 𝒕𝒐𝒕𝒂𝒍 𝒗𝒂𝒍𝒖𝒆 𝒐𝒇 𝑪𝑭𝑨39.5 𝒃𝒊𝒍𝒍𝒊𝒐𝒏. 𝑰𝒏 𝒂𝒅𝒅𝒊𝒕𝒊𝒐𝒏 𝒕𝒐 𝒕𝒉𝒆𝒔𝒆 𝒍𝒆𝒈𝒂𝒍 𝒊𝒎𝒑𝒐𝒓𝒕𝒔, 𝒔𝒎𝒖𝒈𝒈𝒍𝒊𝒏𝒈 𝒂𝒏𝒅 𝒄𝒐𝒖𝒏𝒕𝒆𝒓𝒇𝒆𝒊𝒕 𝒅𝒓𝒖𝒈𝒔 𝒄𝒐𝒏𝒕𝒊𝒏𝒖𝒆 𝒕𝒐 𝒇𝒍𝒐𝒐𝒅 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕, 𝒑𝒖𝒕𝒕𝒊𝒏𝒈 𝒍𝒐𝒄𝒂𝒍 𝒑𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝒃𝒖𝒔𝒊𝒏𝒆𝒔𝒔𝒆𝒔 𝒖𝒏𝒅𝒆𝒓 𝒔𝒊𝒈𝒏𝒊𝒇𝒊𝒄𝒂𝒏𝒕 𝒑𝒓𝒆𝒔𝒔𝒖𝒓𝒆.

𝑫𝒆𝒔𝒑𝒊𝒕𝒆 𝒕𝒂𝒍𝒌𝒔 𝒐𝒇 𝒊𝒎𝒑𝒐𝒓𝒕 𝒔𝒖𝒃𝒔𝒕𝒊𝒕𝒖𝒕𝒊𝒐𝒏 𝒂𝒏𝒅 𝒑𝒓𝒐𝒎𝒐𝒕𝒊𝒏𝒈 𝒍𝒐𝒄𝒂𝒍 𝒑𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏, 𝑪𝒂𝒎𝒆𝒓𝒐𝒐𝒏 𝒄𝒐𝒏𝒕𝒊𝒏𝒖𝒆𝒔 𝒕𝒐 𝒊𝒎𝒑𝒐𝒓𝒕 𝒐𝒗𝒆𝒓 90% 𝒐𝒇 𝒊𝒕𝒔 𝒑𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝒏𝒆𝒆𝒅𝒔, 𝒂𝒄𝒄𝒐𝒓𝒅𝒊𝒏𝒈 𝒕𝒐 𝒐𝒇𝒇𝒊𝒄𝒊𝒂𝒍 𝒇𝒊𝒈𝒖𝒓𝒆𝒔. 𝑳𝒐𝒄𝒂𝒍 𝒑𝒓𝒐𝒅𝒖𝒄𝒆𝒓𝒔 𝒔𝒕𝒓𝒖𝒈𝒈𝒍𝒆 𝒕𝒐 𝒄𝒂𝒑𝒕𝒖𝒓𝒆 𝒎𝒐𝒓𝒆 𝒕𝒉𝒂𝒏 𝑪𝑭𝑨8 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒐𝒇 𝒂 𝒎𝒂𝒓𝒌𝒆𝒕 𝒗𝒂𝒍𝒖𝒆𝒅 𝒂𝒕 𝒐𝒗𝒆𝒓 𝑪𝑭𝑨125 𝒃𝒊𝒍𝒍𝒊𝒐𝒏. 𝑫𝒖𝒓𝒊𝒏𝒈 𝒂 𝒎𝒆𝒆𝒕𝒊𝒏𝒈 𝒘𝒊𝒕𝒉 𝒕𝒉𝒆 𝑴𝒊𝒏𝒊𝒔𝒕𝒆𝒓 𝒐𝒇 𝑻𝒓𝒂𝒅𝒆 𝒐𝒏 𝑶𝒄𝒕𝒐𝒃𝒆𝒓 1, 2021, 𝑳𝒐𝒆 𝑮𝒊𝒔è𝒍𝒆 𝑬𝒕𝒂𝒎𝒆, 𝑷𝒓𝒆𝒔𝒊𝒅𝒆𝒏𝒕 𝒐𝒇 𝒕𝒉𝒆 𝑨𝒔𝒔𝒐𝒄𝒊𝒂𝒕𝒊𝒐𝒏 𝒐𝒇 𝑷𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝑰𝒏𝒅𝒖𝒔𝒕𝒓𝒊𝒆𝒔, 𝒏𝒐𝒕𝒆𝒅 𝒕𝒉𝒂𝒕 𝒍𝒐𝒄𝒂𝒍 𝒑𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏 𝒖𝒏𝒊𝒕𝒔 𝒘𝒆𝒓𝒆 𝒐𝒑𝒆𝒓𝒂𝒕𝒊𝒏𝒈 𝒂𝒕 𝒋𝒖𝒔𝒕 20% 𝒐𝒇 𝒕𝒉𝒆𝒊𝒓 𝒄𝒂𝒑𝒂𝒄𝒊𝒕𝒚.

𝑫𝒓. 𝑷𝒓𝒐𝒔𝒑𝒆𝒓 𝑯𝒊𝒂𝒈, 𝑪𝒉𝒂𝒊𝒓𝒎𝒂𝒏 𝒐𝒇 𝒕𝒉𝒆 𝑩𝒐𝒂𝒓𝒅 𝒐𝒇 𝑨𝒇𝒓𝒊𝒄𝒖𝒓𝒆 𝑷𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍𝒔 𝑪𝒂𝒎𝒆𝒓𝒐𝒐𝒏 (𝑨𝑷𝑪), 𝒂 𝑫𝒐𝒖𝒂𝒍𝒂-𝒃𝒂𝒔𝒆𝒅 𝒅𝒓𝒖𝒈 𝒎𝒂𝒏𝒖𝒇𝒂𝒄𝒕𝒖𝒓𝒊𝒏𝒈 𝒖𝒏𝒊𝒕, 𝒔𝒂𝒊𝒅 𝒕𝒉𝒆 𝒔𝒊𝒕𝒖𝒂𝒕𝒊𝒐𝒏 𝒉𝒂𝒔 𝒘𝒐𝒓𝒔𝒆𝒏𝒆𝒅 𝒊𝒏 𝒓𝒆𝒄𝒆𝒏𝒕 𝒚𝒆𝒂𝒓𝒔 𝒅𝒖𝒆 𝒕𝒐 𝒇𝒊𝒏𝒂𝒏𝒄𝒊𝒂𝒍 𝒅𝒊𝒇𝒇𝒊𝒄𝒖𝒍𝒕𝒊𝒆𝒔 𝒂𝒕 𝒕𝒉𝒆 𝑵𝒂𝒕𝒊𝒐𝒏𝒂𝒍 𝑪𝒆𝒏𝒕𝒆𝒓 𝒇𝒐𝒓 𝑬𝒔𝒔𝒆𝒏𝒕𝒊𝒂𝒍 𝑴𝒆𝒅𝒊𝒄𝒊𝒏𝒆𝒔 𝑺𝒖𝒑𝒑𝒍𝒚 (𝑪𝒆𝒏𝒂𝒎𝒆). 𝑨𝒄𝒄𝒐𝒓𝒅𝒊𝒏𝒈 𝒕𝒐 𝑫𝒓. 𝑯𝒊𝒂𝒈, 𝑪𝒆𝒏𝒂𝒎𝒆, 𝒘𝒉𝒊𝒄𝒉 𝒊𝒎𝒑𝒐𝒓𝒕𝒆𝒅 𝒎𝒆𝒅𝒊𝒄𝒊𝒏𝒆𝒔 𝒘𝒐𝒓𝒕𝒉 𝑪𝑭𝑨15 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2011, 𝒔𝒑𝒆𝒏𝒕 𝒐𝒏𝒍𝒚 𝑪𝑭𝑨3 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒐𝒏 𝒕𝒉𝒆 𝒍𝒐𝒄𝒂𝒍 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒏 2020.

𝑻𝒐 𝒓𝒆𝒗𝒆𝒓𝒔𝒆 𝒕𝒉𝒊𝒔 𝒕𝒓𝒆𝒏𝒅, 𝒍𝒐𝒄𝒂𝒍 𝒑𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝒎𝒂𝒏𝒖𝒇𝒂𝒄𝒕𝒖𝒓𝒆𝒓𝒔 𝒉𝒂𝒗𝒆 𝒖𝒓𝒈𝒆𝒅 𝒕𝒉𝒆 𝒈𝒐𝒗𝒆𝒓𝒏𝒎𝒆𝒏𝒕 𝒕𝒐 𝒇𝒂𝒄𝒊𝒍𝒊𝒕𝒂𝒕𝒆 𝒂𝒄𝒄𝒆𝒔𝒔 𝒕𝒐 𝒑𝒖𝒃𝒍𝒊𝒄 𝒑𝒓𝒐𝒄𝒖𝒓𝒆𝒎𝒆𝒏𝒕. 𝑻𝒉𝒆𝒚 𝒔𝒖𝒈𝒈𝒆𝒔𝒕 𝒕𝒉𝒂𝒕 𝒔𝒑𝒆𝒄𝒊𝒇𝒊𝒄 𝒑𝒖𝒃𝒍𝒊𝒄 𝒉𝒆𝒂𝒍𝒕𝒉 𝒏𝒆𝒆𝒅𝒔 𝒔𝒉𝒐𝒖𝒍𝒅 𝒃𝒆 𝒎𝒆𝒕 𝒕𝒉𝒓𝒐𝒖𝒈𝒉 𝒏𝒂𝒕𝒊𝒐𝒏𝒂𝒍 𝒕𝒆𝒏𝒅𝒆𝒓𝒔 𝒓𝒆𝒔𝒆𝒓𝒗𝒆𝒅 𝒇𝒐𝒓 𝒍𝒐𝒄𝒂𝒍 𝒎𝒂𝒏𝒖𝒇𝒂𝒄𝒕𝒖𝒓𝒆𝒓𝒔, 𝒅𝒆𝒑𝒆𝒏𝒅𝒊𝒏𝒈 𝒐𝒏 𝒕𝒉𝒆𝒊𝒓 𝒑𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏 𝒄𝒂𝒑𝒂𝒄𝒊𝒕𝒚.

𝑺𝒐𝒖𝒓𝒄𝒆: 𝑩𝒖𝒔𝒊𝒏𝒆𝒔𝒔 𝒊𝒏 𝑪𝒂𝒎𝒆𝒓𝒐𝒐𝒏